Your browser doesn't support javascript.
Statistical modeling of SARS-CoV-2 substitution processes: predicting the next variant.
Levinstein Hallak, Keren; Rosset, Saharon.
  • Levinstein Hallak K; Department of Statistics and Operations Research, School of Mathematical Sciences, Tel-Aviv University, 6997801, Tel-Aviv, Israel.
  • Rosset S; Department of Statistics and Operations Research, School of Mathematical Sciences, Tel-Aviv University, 6997801, Tel-Aviv, Israel. saharon@tauex.tau.ac.il.
Commun Biol ; 5(1): 285, 2022 03 29.
Article in English | MEDLINE | ID: covidwho-1768863
ABSTRACT
We build statistical models to describe the substitution process in the SARS-CoV-2 as a function of explanatory factors describing the sequence, its function, and more. These models serve two different

purposes:

first, to gain knowledge about the evolutionary biology of the virus; and second, to predict future mutations in the virus, in particular, non-synonymous amino acid substitutions creating new variants. We use tens of thousands of publicly available SARS-CoV-2 sequences and consider tens of thousands of candidate models. Through a careful validation process, we confirm that our chosen models are indeed able to predict new amino acid substitutions candidates ranked high by our model are eight times more likely to occur than random amino acid changes. We also show that named variants were highly ranked by our models before their appearance, emphasizing the value of our models for identifying likely variants and potentially utilizing this knowledge in vaccine design and other aspects of the ongoing battle against COVID-19.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Limits: Humans Language: English Journal: Commun Biol Year: 2022 Document Type: Article Affiliation country: S42003-022-03198-y

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Limits: Humans Language: English Journal: Commun Biol Year: 2022 Document Type: Article Affiliation country: S42003-022-03198-y